Advances in the evaluation and prediction of the efficacy of allergen-specific immunotherapy
10.3760/cma.j.cn112150-20241125-00943
- VernacularTitle:过敏原特异性免疫治疗的疗效评价及预测的研究进展
- Author:
Minghui YU
1
;
Xing YANG
1
;
Wenqi CHE
1
;
Lu ZHANG
1
;
Huanping ZHANG
1
Author Information
1. 山西医科大学第三医院过敏反应科,太原 030032
- Publication Type:Journal Article
- Keywords:
Allergen-specific Immunotherapy;
Evaluation of efficacy;
Prediction of efficacy
- From:
Chinese Journal of Preventive Medicine
2025;59(6):795-804
- CountryChina
- Language:Chinese
-
Abstract:
Allergen-specific Immunotherapy (AIT) is currently the only allopathic treatment capable of modifying the natural course of immunoglobulin E (IgE)-mediated allergic diseases. Currently, there is a lack of recognized clinical markers for evaluating and predicting the efficacy of AIT, and some biological markers may have some potential for application. This article will summarize the currently known indicators for evaluating and predicting the therapeutic effects of AIT, with the aim of providing assistance in evaluating and monitoring the efficacy of AIT.